WallStreetZenWallStreetZen

NASDAQ: ADXN
Addex Therapeutics Ltd Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsRevenueDividendOwnership

Be the first to know when Wall Street analysts revise their ADXN stock forecasts and price targets.

Forecast return on equity

Is ADXN forecast to generate an efficient return?

Company
-4,429.9%
Industry
134.01%
Market
46.57%
ADXN's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is ADXN forecast to generate an efficient return on assets?

Company
-4,027.24%
Industry
103.31%
ADXN is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

ADXN revenue forecast

What is ADXN's revenue in the next 1 years based on estimates from 1 analyst?

Avg 1 year Forecast
$940.0k+34.88%

ADXN vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
ADXN$6.75N/AN/A
GNPX$0.23N/AN/A
SPRB$0.12$1.75+1,346.28%Hold
IBO$0.42N/AN/A
BCLI$0.86N/AN/A
View Top Biotech Stocks

Addex Therapeutics Stock Forecast FAQ

What is ADXN's revenue growth forecast for 2025-2025?

(NASDAQ: ADXN) Addex Therapeutics's forecast annual revenue growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of N/A, and while it is not forecast to beat the US market's average forecast revenue growth rate of N/A.

Addex Therapeutics's revenue in 2025 is $665,574.

In 2025, ADXN is forecast to generate $92,424,278 in revenue, with the lowest revenue forecast at $92,424,278 and the highest revenue forecast at $92,424,278.

If you're new to stock investing, here's how to buy Addex Therapeutics stock.

What is ADXN's forecast return on assets (ROA) for 2025-2025?

(NASDAQ: ADXN) forecast ROA is -4,027.24%, which is lower than the forecast US Biotechnology industry average of 103.31%.

What is ADXN's forecast return on equity (ROE) for 2025-2025?

(NASDAQ: ADXN) forecast ROE is -4,429.9%, which is considered weak.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.